HCC shows molecular alterations in the early stage of carcinogenesis, including activation of the Nrf2 pathway that contributes to the progression of preneoplastic lesions along the path of malignant evolution [4]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.